Philadelphia-based Rothman Orthopaedics has renewed the terms of three physician leaders, with the new appointments set to begin at the end of 2026.
Alexander Vaccaro, MD, PhD, was unanimously re-elected as president. Dr. Vaccaro has served in the role since 2014 and also chairs orthopaedics at Thomas Jefferson University Kimmel Medical Center, according to a Dec. 8 news release shared with Becker’s.
Gerald Williams, MD, was re-elected as chairman of the board of directors, a role he has held since 2022. Pedro Beredjiklian, MD, was re-elected as vice president of clinical affairs, a post he has held since 2020. Both terms take effect Jan. 1, 2026.
“The leadership of Drs. Vaccaro, Williams and Beredjiklian have helped establish Rothman Orthopaedics as one of the most respected orthopedic organizations in the world,” Christian Ellison, CEO of Rothman Orthopaedics, said in the release. “I’m excited to partner with them, the Board and our leadership team to expand our impact, advance clinical innovation and deliver outstanding care to our patients.”
Rothman Orthopaedics operates 32 locations across multiple states and provides specialty services spanning spine, joint replacement, sports medicine, oncology and other orthopedic subspecialties.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
